Charles Explorer logo
🇬🇧

Amplifying Efficiency and Accuracy in Dementia Drug Development

Publication at Second Faculty of Medicine |
2024

Abstract

Authors, reviewers, and readers of peer-reviewed journals, such as the Journal of Prevention of Alzheimer's Disease, fully understand the burden of neurodegenerative disorders. Descriptions often note global estimates of dementia incidence, high long-term care costs, challenges to detection or diagnosis outside of specialty clinic populations, an inadequate healthcare workforce, fragmented healthcare services, and the prolonged, uncompensated, and variable nature of caring for cognitive, behavioral, and functional impairments imposed on people living with dementia.

Since the late 20th century, the mission of the global dementia research enterprise has been to keep everyone functionally independent and autonomous for as long as possible before requiring expensive and often long-lasting personal care. Yet despite this focus, a question remains: does the current research environment have the capacity and resources to deliver effective, timely, and accurate interventions to individuals living with the specter of dementia?.